Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: Am J Kidney Dis. 2012 Jan 11;59(4):569–576. doi: 10.1053/j.ajkd.2011.11.035

Table 2. Primary Outcome Data.

Study Primary Outcome Lower Dose Mortality Higher Dose Mortality Risk Ratio
Ronco et al(2000) 13 Mortality at 15 days after stopping CVVH 59% 42.5% 0.72
Bouman et al (2002)15 Mortality at 28 days after inclusion 28.1% 25.7% 0.91
Saudan et al (2006)16 Mortality at 28 and 90 days 61% 41% 0.67
Tolwani et al (2008)17 Mortality at 30 days or survival to ICU discharge 44% 51% 1.16
Bellomo et al (2009)19 Mortality at 90 days after randomization 44.7% 44.7% 1.00
Schiffl et al (2002)14 Mortality at 14 days after las hemodialysis t 46% 28% 0.61
Faulhaber-Walter et al (2009)20 Mortality at 14 days after initiation of dialysis 29.3% 29.6% 1.01
Palevsky et al (2008)18 Mortality at 60 days after randomization 51.5% 53.6% 1.04

Summary 0.89

Abbreviations: CVVH, continuous veno-venous hemofiltration; ICU, intensive care unit